Search - tctmd.com

Displaying 321 - 340 of 467

Sort: Relevancy | Date

News Conference News ESC 2018

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

Michael O'Riordan

August 26, 2018

News Daily News

High LDL and Non-HDL Cholesterol Tied to CV Mortality Even in Low-Risk Individuals

Lucy Hicks

August 21, 2018

News Daily News

Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases

Michael O'Riordan

August 16, 2018

News Daily News

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Caitlin E. Cox

August 15, 2018

News Daily News

US Preventive Services Task Force: Insufficient Evidence to Recommend ECG Screening for A-fib Detection

L.A. McKeown

August 07, 2018

News Daily News

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Yael L. Maxwell

August 03, 2018

News Daily News

Starting Low and Going Lower: Some Benefit to Very Low LDL Levels

Michael O'Riordan

August 02, 2018

News Daily News

Peer Pressure May Push Physicians to Do Better at Prescribing Statins

Lucy Hicks

July 30, 2018

News Conference News SCCT 2018

Think Like a Patient: Rationale and Resources for Shared Decision-Making in Cardiology

Yael L. Maxwell

July 13, 2018

News Daily News

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

Michael O'Riordan

July 12, 2018

News Daily News

Clinical Benefit of Lowering Lp(a) Is Proportional to Its Absolute Reduction: Mendelian Randomization Analysis

Yael L. Maxwell

June 25, 2018

News Daily News

Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle

Michael O'Riordan

June 18, 2018

News Daily News

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

Todd Neale

June 04, 2018

News Conference News EAS 2018

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Yael L. Maxwell

May 11, 2018

News Conference News EAS 2018

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Yael L. Maxwell

May 07, 2018

News Daily News

LPA Variants Linked With CHD Events in Statin-Treated Patients

Michael O'Riordan

May 03, 2018

News Daily News

The Higher the LDL, the Bigger the Mortality Benefit of Intensive Therapy: Meta-analysis

Michael O'Riordan

April 20, 2018

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

News Daily News

Uptick Seen in Medication Adherence Among Hypertensive Patients Using Mobile App

Michael O'Riordan

April 16, 2018

News Daily News

Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say

Michael O'Riordan

April 09, 2018

Advertisement

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

High LDL and Non-HDL Cholesterol Tied to CV Mortality Even in Low-Risk Individuals

Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

US Preventive Services Task Force: Insufficient Evidence to Recommend ECG Screening for A-fib Detection

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Starting Low and Going Lower: Some Benefit to Very Low LDL Levels

Peer Pressure May Push Physicians to Do Better at Prescribing Statins

Think Like a Patient: Rationale and Resources for Shared Decision-Making in Cardiology

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

Clinical Benefit of Lowering Lp(a) Is Proportional to Its Absolute Reduction: Mendelian Randomization Analysis

Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

LPA Variants Linked With CHD Events in Statin-Treated Patients

The Higher the LDL, the Bigger the Mortality Benefit of Intensive Therapy: Meta-analysis

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Uptick Seen in Medication Adherence Among Hypertensive Patients Using Mobile App

Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content